Hypofractionated radiation, SBRT, has been shown to stimulate the immune response by increasing T cell abundance and activation in the TME and to lead to significant tumor growth reduction when combined with anti-PD-1/PD-L1 inhibitors22,23 (NCT02383212) (refs. 24,25). The gene discussed is CD274; the disease is neoplasm.